https://powellmatt.com/insights/ Matt Powell builds pharma intelligence software: patient advocacy mapping, unmet-need research from public conversation, FDA/EMA monitoring, and PMCPA compliance tools. Solo founder of Phormulate Ltd and Elliogen. en-GB https://powellmatt.com/insights/building-regulated-pharma-saas-solo/ https://powellmatt.com/insights/building-regulated-pharma-saas-solo/ Thu, 13 Aug 2026 00:00:00 GMT How I ship life-sciences software alone — VPS infrastructure, Coolify, Tailscale, static front ends, and the compliance trade-offs you cannot skip. https://powellmatt.com/insights/finding-scoring-patient-advocacy-groups/ https://powellmatt.com/insights/finding-scoring-patient-advocacy-groups/ Thu, 13 Aug 2026 00:00:00 GMT A patient advocacy group database is not a spreadsheet of logos. Here is what to map, what to score, and why one-off agency reports go stale. https://powellmatt.com/insights/france-life-sciences-market-entry/ https://powellmatt.com/insights/france-life-sciences-market-entry/ Thu, 13 Aug 2026 00:00:00 GMT A practical, non-legal checklist for pharma and medtech market entry in France — access, presence, promotion, and what not to copy from the UK or US playbook. https://powellmatt.com/insights/patient-unmet-needs-from-public-conversation/ https://powellmatt.com/insights/patient-unmet-needs-from-public-conversation/ Thu, 13 Aug 2026 00:00:00 GMT Social listening for pharma brand teams usually reports sentiment. Unmet-need research is different — named needs, in a specific indication, with a quote attached. https://powellmatt.com/insights/pmcpa-compliance-promotional-materials/ https://powellmatt.com/insights/pmcpa-compliance-promotional-materials/ Thu, 13 Aug 2026 00:00:00 GMT How to get UK medicines promotional materials closer to PMCPA-ready — claims, evidence, reference packs, and the failure modes that waste MLR time.